FDA NDC Directory · JSON-LD · Markdown

Rezvoglar KwikPen

NDC 0002-8980 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameInsulin glargine-aglr
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA761215
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN GLARGINE (100 [iU]/mL)
Marketing started20211217
Package count1

External sources

Source: openFDA. Public-domain (CC0).